EU Set to Open Doors to Imported Carbon Credits Under 2040 Goal
The European Union wants to allow limited imports of carbon credits under a planned 90% emissions reduction goal for the next decade, in a bid to reduce the costs of its ambitious green shift and get member states on board.
The European Commission, the bloc's executive arm, is poised to propose that certain high-quality credits from a new United Nations-supervised mechanism can account for 3% of the pollution cut by 2040, according to a draft document seen by Bloomberg News.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Bitvavo Secures a MiCA License From the Netherlands
Bitvavo is the latest crypto exchange to receive a Markets in Crypto Assets License from the Dutch Authority for the Financial Markets (AFM) to operate across the 30 nations in the European Economic Area. Crypto companies have been applying for the licenses since the regulatory regime came into force in December last year. MiCA, which came into force in 2023 harmonizes rules across the European Union's bloc of 27 nations plus Iceland, Norway and Liechtenstein. The Netherlands also awarded licenses to four exchanges in December last year, as the rules took effect. Other exchanges like OKX, and Bitpanda secured a MiCA license from Malta. Kraken was awarded a license on Thursday from Ireland, Coinbase was awarded a MiCA license from Luxembourg in June and Bybit was awarded an EU license from Austria in May. "This license provides clarity, confidence and enables Bitvavo to fulfil its ambition: to become the leading digital asset trading platform in Europe," said Mark Nuvelstijn, CEO and co-founder of Bitvavo, in a statement. Bitvavo, which is the largest player globally in the EUR spot market, already held registrations in France, Austria, Italy and Spain, in addition to the Netherlands, the company's release said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
37 minutes ago
- Yahoo
TD Cowen Starts Coverage Soleno Therapeutics (SLNO) Stock, Gives Buy
Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds. On June 23, TD Cowen analyst Tyler Van Buren began coverage of the company's stock with a 'Buy' rating and a price objective of $110, as reported by The Fly. The firm highlighted VYKAT XR as the first-approved treatment for hyperphagia in Prader-Willi syndrome (PWS). As per the firm, the drug bucked the trend of clinical shortcomings in PWS by securing the regulatory approval. A clinical-stage biopharmaceutical company's boardroom, emphasizing the importance of decision-making for the lead candidate development of a once-daily oral tablet. The firm demonstrated confidence in Soleno Therapeutics, Inc. (NASDAQ:SLNO)'s management team, mentioning that they seem to be prepared to execute a strong launch with a high price tag and sizable population to itself. The analysis exhibits that the company has positioned itself for commercial success. The firm remains optimistic and believes that the PWS community's urgency is expected to drive significant uptake of VYKAT XR, reflecting robust demand potential among patients and caregivers. Soleno Therapeutics, Inc. (NASDAQ:SLNO) also announced that its Marketing Authorization Application (MAA) seeking regulatory approval of Diazoxide Choline Prolonged-Release Tablets for the treatment of adults and children aged 4 years and older with PWS, who possess hyperphagia, had been validated by the EMA (European Medicines Agency). TimesSquare Capital Management, an equity investment management company, released its Q1 2025 investor letter. Here is what the fund said: 'Our preferences among Health Care stocks are those companies providing novel therapies for unmet needs that deserve premium pricing, or specialized service providers. Soleno Therapeutics, Inc. (NASDAQ:SLNO) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare diseases. The FDA granted approval of Vyvkat for treating Prader Willi syndrome, a rare genetic disorder that causes life-threatening obesity in children. That development served to boost the stock price by 60% and we decided to book some of the profits by cutting back on the investment.' While we acknowledge the potential of SLNO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SLNO and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Wall Street Journal
an hour ago
- Wall Street Journal
Why Shouldn't Europe Seize Russia's Assets?
Your editorial 'Trump Wins the Battle of NATO' (June 26) notes the good news: Our European allies are finally going to pony up more for their security. But when it comes to Russia's illegal and unprovoked invasion of Ukraine, our treaty allies shouldn't only commit additional billions to defense. They should also seize frozen Russian sovereign assets as a powerful form of deterrence. Having immobilized an estimated €210 billion of Russian funds, Europe can impose additional costs on Moscow through confiscation, diverting many of these resources to Ukraine's defense. I co-authored the REPO Act, which allows for the seizure of Russian sovereign assets in the U.S. Though President Biden signed the bill in April 2024, the White House chose not to use it for months. With President Trump at the helm, we can end the Biden-era policy of hesitation and move swiftly to implement the law—starting by transferring $5 billion in immobilized Russian funds held in the U.S. to Ukraine. If NATO countries are making the significant choice to spend more on defense, using Russia's frozen assets should be an easy decision. How can NATO members urge their taxpayers to chip in more while letting Vladimir Putin off the hook?
